Abstract: A composition comprising (a) soy protein, (b) a phytoestrogen compound, and (c) dietary fibers. The soy protein (a) is present in an amount of at least 45 weight percent of the total protein content of the composition, said total protein content providing at least 15 percent of the total energy content of the composition. The phytoestrogen compound (b) is preferably a naturally occuring isoflavone and is present in an amount of more than 0.10 weight percent of the soy protein, and the dietary fibers (c) are preferably soybean fibers and are present in an amount of more than 4 weight percent of the total weight of the nutritional composition on a dry basis. The composition is useful in lowering serum cholesterol and LDL-cholesterol and serum triglyceride levels and for increasing the HDL/LDL-cholesterol ratio in serum of a subject suffering from arteriosclerosis and related cardiovascular diseases.

Abstract: The present invention relates to a process of providing an extract containing at least one simmondsin compound. The extract is provided from jojoba plant, and used as a dietary supplement for use in a weight control regiment in humans. The present invention also provides a method of treating an overweight human in need of such treatment, and comprises administering a therapeutically effective amount of such an extract.

Abstract: A preparation similar to sebum to be used as lipidic component in formulations to be administered topically is characterized in that it consits of active principale of only natural origin capable of fulfilling the requirement of meeting the average qualitative-quantitative composition of the human dermal surface lipides. In particular, it consits of substances of natural origin capable of providing triglycerides which are rich in saturated, monounsaturated and diunsaturated acids, squalene, waxes, free and esterified cholesterol in quantities which are equivalent to those present in the human sebum.

Abstract: Disclosed is a composition that includes a material that is susceptible to degradation and a preserving agent in an amount effective to preserve the material comprising one or more reduced malto-oligosaccharide species. The preserving agent can include a single reduced malto-oligosaccharide species or a plurality of such species. Further disclosed is a method of preserving a material. The method generally includes contacting the material with a preserving agent containing a preserving effective amount of one or more reduced malto-oligosaccharide species. Solutions, powders, glasses, gels, and the like containing the chemically reactive material(s) and a preserving effective amount of one or more reduced malto-oligosaccharide species may be prepared.

Abstract: The present invention provides a novel method for simultaneously inhibiting the cyclooxygenase COX-2 and 5-lipoxygenase (5-LO) enzymes. The method for the simultaneous dual inhibition of COX-2 and 5-LO is comprised of administering a composition containing an individual and/or a mixture of multiple flavans isolated from a single plant or multiple plants in the Acacia genus of plants to a host in need thereof. The present also includes novel methods for the prevention and treatment of COX-2 and 5-LO mediated diseases and conditions. The method for preventing and treating COX-2 and 5-LO mediated diseases and conditions is comprised of administering to a host in need thereof an effective amount of a composition comprising an individual and/or a mixture of multiple flavans isolated from a single plant or multiple plants in the Acacia genus of plants and a pharmaceutically acceptable carrier.

Abstract: The invention relates to a microwave assisted process for the preparation of hydroxylated lecithin from soybean lecithin comprising hydroxylating crude soybean lecithin by using hydrogen peroxide and lactic acid as hydroxylating agent through microwave irradiation.

Abstract: The present invention provides a method of treating or preventing certain medical conditions with isoflavones. More specifically, the invention provides a method of treating or preventing one or more of the following medical conditions: hepatic steatosis, steatohepatitis, insulin resistance, impaired glucose tolerance, syndrome X, abnormal platelet function, or abnormal vascular reactivity, with compositions containing isoflavones.

Abstract: The invention relates to the use of extracts of the Cassia alata plant in cosmetic and/or dermatological skin care products.

Abstract: A pharmaceutical composition for prevention and treatment of cancer, cardiovascular disease and antioxidation contains resveratol. The new method of process for producing resveratol is extracted resveratol from oil residue and stems of peanuts or stems of other cheap herbs. Derivates of resveratol include procyanidins, polydatin, peceid, anthraglycoside, emodin, chrysophanol and quercetin.

Abstract: Highly safe cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents and immunosuppressants. Brazilian licorice extract and periandrins, which are constituents thereof, have excellent characteristics of showing effects of inhibiting cytokine production and protecting and promoting liver function, an anti-inflammatory effect and an immunosuppressive effect without any harmful side effects. Thus use of Brazilian licorice extract or periandrins as cytoline production inhibitors makes it possible to inhibit inflammations in various diseases such as rheumatoid arthritis. These substances are also usable as agents for protecting and promoting liver function, anti-inflammatory agents and immunosuppressants. Moreover, foods, cosmetics, sweeteners and food materials containing Brazilian licorice extract exert the effects as described above.

Abstract: Suspensions, emulsions or dispersions of therapeutically active agents which are water insoluble or water intolerant such as nutritional supplements, herbal products, drugs, bacteria, yeast, vitamins and minerals are prepared as suspensions in edible vegetable oils such as orange, lemon, soybean, cotton seed, peanut, canola corn oil, sunflower, safflower, palm kernel, palm and coconut. The active therapeutic agent may be in crystalline or amorphous form, it may be a liquid as for example an oil such as vitamin B or beta carotene, or a preparation of a comminuted plant structure such as flower, parts, leaf; stern, root or tree bark, or an extract of a dried plant structure or a freeze dried preparation of a vital bacteria or yeast. The suspension is formed by active mixing of the active agent and oil.

Abstract: The present invention provides a novel method for inhibiting the cyclooxygenase COX-2. The method is comprised of administering a composition containing a Free-enzyme B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids to a host in need thereof. The present also includes novel methods for the prevention and treatment of COX-2 mediated diseases and conditions. The method for preventing and treating COX-2 mediated diseases and conditions is comprised of administering to a host in need thereof an effective amount of a composition containing a Free-B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids and a pharmaceutically acceptable carrier.

Abstract: The present invention relates to cosmetic compositions that may be topically applied to skin, hair and nails for improving the aesthetic appearance thereof. The present invention also relates to compositions that may be topically applied to skin, hair and nails for ameliorating, forestalling, reducing, preventing, and/or treating the signs of aging due to extrinsic and/or intrinsic factors.

Abstract: A sustained/prolonged release pharmaceutical dosage form is disclosed. The form comprises a hard shell capsule and a formulation comprising (a) a water insoluble medicament, (b) a high melting fatty ester, (c) a low viscosity oil, (d) a cellulosic polymer, and (e) a non-ionic surfactant.

Abstract: An herbal formulation which acts as an intestinal bowel soother is disclosed which comprises: slippery elm bark; German chamomile flower; fenugreek seed; fennel seed; skullcap herb; cranberry fruit; peppermint leaf; a mixture of Chinese herbs, comprising atractylodes root, capillary artemisia herb, codonopsis root, Job's tears seed, schisandra fruit, agastache whole plant, Chinese licorice root, Chinese thoroughwax, ginger root, Korean ash branches bark, magnolia bark, phellodendron bark, poria cocos root, psyllium seed, Chinese goldthread, Chinese white peony root, costus root, silver root, tangerine peel, and angelica root; and methylsulfonylmethane.

Abstract: A stick-type solid water-in-oil type emulsion cosmetic composition having an excellent stability, having a refreshing feeling and freshness after finish when coated on the skin and particularly giving a soft feeling of use when coated, which contains (a) 0.5 to 40.0% by weight of a hydrogenated jojoba oil, (b) 0.1 to 10.0% by weight of a surfactant composed of polyoxyalkylene-modified silicone or alkyl- and polyoxyalkylene-modified silicone and (c) 5.0 to 50.0% by weight of water.

Abstract: This invention relates to compositions containing polyphenols, for example, cocoa polyphenols such as procyanidins, in combination with at least one cholesterol lowering agent, and methods for improving vascular health including treating and preventing atherosclerosis and cardiovascular disease.

Abstract: A method and kit for enhancing the natural fertility process. The kit includes a vaginal douche that is used prior to intercourse to enhance the sperm transportation and sustaining properties of the cervical mucous. The douche contains a balanced electrolyte solution, polysaccharides, and pH buffers. The kit also includes nutriceuticals specifically formulated for both the male and female which include amino acids, minerals, vitamins, herbs, phytoestrogens, and antioxidants along with a specified dosing regimen. A basal body temperature thermometer and chart is provided with instructions to confirm when and if ovulation will/did occur. Commercially available urinary chemical reagent strips are provided with instructions so as to predict/confirm if and when ovulation will occur. A lubricating medium will also be provided and utilized at the time of intercourse which is nonspermicidal and which contains polysaccharides which influence natural sperm motility.

Abstract: There is provided a method of preparing an unsaturated fatty acid dry concentrate, wherein a substance comprising at least one unsaturated fatty acid is applied on a biologically inert matrix having a large surface area and is subsequently dried, as well as a composition comprising at least one unsaturated fatty acid and foods, beverages, drugs comprising this composition.

Abstract: A topical composition and method for the treatment of the symptoms of diaper rashes and skin irritations by creating an air circulating mechanism comprising a) bicarbonate of soda; b) corn starch; c) citric acid; d)a carrier oil; e) a pharmaceutically acceptable moisturizer, f) fragrance oil; and g) food grade coloring. The carrier oil is selected from the group consisting of almond oil, coconut ail, sunflower oil, apricot kernel oil, avocado oil, canola oil, evening primrose oil, grapeseed oil, hazelnut oil, jojoba oil, macadamia oil, dive oil, sesame oil, rosehip seed oil, and mixtures thereof. The pharmaceutically acceptable moisturizer is either purified water or witch hazel. In its preferred embodiments, the composition can result in a loose powder for application directly to the diapered skin, an effervescent bath tablet, and as an additive to the bodyfacing layer of a diaper.

Abstract: A soya extract having a content of glucoside isoflavones of at least 13% by weight and a content of 0.6 to 1.5 parts by weight of group B soya saponins per 1 part by weight of glucoside isoflavones. Also, pharmaceutical compositions containing this extract and methods of administering the extract to treat conditions such as pre- or post-menopausal symptoms, cancer, such as breast or prostrate cancer, or alcoholism. The extracts are made by a process which includes the steps of treating ripe whole soya beans or oil-free soya flour with an aliphatic alcohol to obtain a first extract; concentrating the first extract to form a concentrated first extract; purifying the concentrated first extract by treatment with at least one aliphatic hydrocarbon; and extracting active components from the purified concentrated first extract with a water-immiscible aliphatic alcohol to obtain a second extract. Preferably, the final extract is concentrated and dried to form the desired soya extract.

Abstract: A composition for preventing hair loss and promoting hair growth comprises fenugreek extract and a carrier, for example, hydroxylated lecithin and glycerine. The composition is preferably in the form of a spray which is applied beneath the tongue for translingual absorption.

Abstract: The invention herein relates to a topical liquid composition for promoting hair growth, comprising natural ingredients with no side-effects, which is effective in promoting hair growth and preventing hair loss. More particularly, the invention relates to the topical liquid composition for promoting hair growth, comprising the extracts which are formed by immersing the mixture of powders of Pinelliae Rhizoma, Caryophylli Flos, Rubi Fructus, Zanthoxyli Fructus, Viticis Fructus, Salviae Radix, and Thujae Semen in oil and ethanol, respectively, followed by aging for a fixed period of time.

Abstract: The present invention relates to dietary supplements. In particular, the present invention provides compositions and methods utilizing dietary supplements comprising fungus and bacteria co-culture growth media. In preferred embodiments, the bacteria is Gluconacetobacter europaeus or Bacillus pumilus or a combination thereof and the fungus is Zygosaccharomyces. The microorganisms are preferably substantially removed from the growth media. In preferred embodiments, the growth media is dried down, lyophilized, or spray dried to provide a powder.

Abstract: A method of producing an enriched flavonoid aglycone extract from starting material containing a suitable flavonoid glycoside and/or conjugate thereof comprising the steps of: (i) enzymatically converting the flavonoid glycoside or conjugate thereof into the flavonoid aglycone; (ii) adjusting the pH to render the flavonoid aglycone soluble and removing the insoluble fraction; and (iii) adjusting the pH to render the soluble flavonoid aglycone relatively insoluble and forming an extract containing the same.

Abstract: A pharmaceutical composition formulated for sustained release is disclosed. In one embodiment, the pharmaceutical composition comprises cyclosporin and a release modifier encapsulated in a biodegradable polymer. In a preferred embodiment, the release modifier is selected from the group consisting of hydrophilic release modifiers, lipophilic release modifiers, and combinations thereof. Most preferably, the release modifier comprises at least one hydrophilic release modifier and at least one lipophilic release modifier.

Abstract: A method for altering the ratio of total daidzein to total genistein in isoflavonoid-producing plants by using a C1 myb transcription factor and an R-type myc transcription factor is described. Also described are plant comprising these transcription factors in their genome as well as isoflavonoid-containing products made from seeds of these plants. Such products have an increased ratio of total daidzein to total genistein when compared to the total daidzein to total genistein ratio of a control.

Abstract: Herbal compositions and methods suitable for weight loss management and for treating diabetes are disclosed. The compositions comprise Ferula hermonis or an extract thereof, or Ferula hermonis with selected herbs, extracts thereof, and mixture thereof. The methods of reducing weight, and treating diabetes in patients involve oral administration of the compositions. The invention further relates to a method of extracting and standardizing Ferula hermonis extracts and tincture useful for human health.

Abstract: Topical anti-inflammatory compositions are described that include effective amounts of a linseed extract and a licorice extract. In addition, methods of reducing inflammation are described, which include applying topically to a site of inflammation an effective amount of a composition comprising a linseed extract and a licorice extract.

Abstract: The invention relates to sterile pharmaceutical compositions for parenteral administration which comprise an oil-in-water emulsion in which a free radical scavenging sedative agent dissolved in an omega-3 rich water-immiscible solvent, is emulsified with water and stabilised by means of a surfactant, the composition being suitable either directly or after dilution with a liquid diluent for parenteral administration to a warm-blooded animal; in particular to such compositions comprising propofol, and which optionally further comprise a metal ion chelating agent (such as edetate), and the use of such compositions in improving survival in critically ill patients.

Abstract: A method for the treatment, prophylaxis, amelioration or prevention of disorders associated with abnormally high activity of steroidal estrogens, which includes administering to a human subject a composition comprising an isoflavone-containing extract of clover or chick peas, said extract comprising primarily biochanin, or a ratio of biochanin to one or more of the isoflavones from the group formononetin, daidzein and genistein in the range of from about 2:1 to about 5:1, optionally in association with one or more pharmaceutically acceptable carriers, excipients, auxiliaries and/or diluents is described. Also described are compositions and uses comprising the isoflavone containing extracts.

Abstract: The present invention provides a method of treating or preventing certain medical conditions with isoflavones. More specifically, the invention provides a method of treating or preventing one or more of the following medical conditions: hepatic steatosis, steatohepatitis, insulin resistance, impaired glucose tolerance, syndrome X, abnormal platelet function, or abnormal vascular reactivity, with compositions containing isoflavones.

Abstract: The invention includes a nonformulated, low-dose hypocholesterolemic composition comprising soya proteins and &bgr;-sitosterol, wherein the soya proteins and the &bgr;-sitosterol are present in a weight ratio of about 6±1.5 of the soya proteins to about 1±0.2 of the &bgr;-sitosterol; and wherein the composition is made up as an optimal daily dose of only the two components for adults or for children.

Abstract: The present invention relates to a herbal health protective, promotive neutraceutical formulation for women, human expectant mothers and lactating mothers, and also relates to a process for the preparation of custom made herbal health protective, promotive nutraceutical formulations as food supplements to ameliorate the general health of females with optimum nutrients, said process comprises the base product of microwave oven roasted seed powders mixture from selected genera of Glycine, Phaseolus, Cicer, Psophocarpus, Mucuna, Triticum, Hordeum, Amaranthus, Chenopodium and Fagopyrum, fortified with the natural herbs/medicinal plants extract from the genera Centella, Withania, Pueraria, Asparagus, Chlorophytum, Boerhaavia, Sida, Saraca and also some other ingredients like pale sugar powder, jaggary, milk powder, coca powder, Elettaria cardamomum (Elaichi) powder, Piper longum (Pippali) fruit powder, Myristica fragrans (Jaiphal) fruit powder were also added to get the final nutraceuticals; the nutraceuticals are

Abstract: The present invention is directed to methods and compositions regarding induction of apoptosis in a cell and treatment of cancer in an individual wherein methionine deprivation of the cell is followed by methionine repletion of the cell. The methionine deprivation of the cell results in G2 arrest in the cell, leading to DNA damage in the cell. Upon readministration of methionine to the cell, the damaged cell exits G2 arrest and enters into apoptosis. In a specific embodiment, a therapeutic effect is elicited by cycling the patient between a methionine-depleted diet and a normal, methionine-replete diet. The present invention also regards chronic methionine deprivation for treatment of cancer in a human, in addition to methods for methionine restriction as adjunctive therapy for other cancer treatment methods.

Abstract: An herbal formulation comprises: slippery elm bark; German chamomile flower; fenugreek seed; fennel seed; skullcap herb; cranberry fruit; peppermint leaf; a mixture of Chinese herbs, comprising atractylodes root, capillary artemisia herb, codonopsis root, Job's tears seed, schisandra fruit, agastache whole plant, Chinese licorice root, Chinese thoroughwax, ginger root, Korean ash branches bark, magnolia bark, phellodendron bark, poria cocos root, psyllium seed, Chinese goldthread, Chinese white peony root, costus root, silver root, tangerine peel, and angelica root; and methylsulfonylmethane.

Abstract: The invention concerns the use of at least a fatty ester for preparing a composition designed to inhibit 5&agr;-reductase activity. Said use produces a remarkable inhibiting effect of 5&agr;-reductase thereby providing a novel response for treating dermatological pathologies and/or disorders related to congenital or acquired exaggeration of 5&agr;-reductase activity, in particular for treating prostatic hypertrophy, prostatic adenoma, acne, hyperseborrhea, alopecia and hirsutism. The invention also concerns cosmetic treatment methods, in particular for greasy skin, and the use of said fatty esters as additives in a food product for human and/or animal consumption.

Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a soy molasses material. The soy molasses material is derived from a soy material selected from soy flour, soy flakes, soy grit, or soy meal. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.

Abstract: The present invention relates to compositions for the protection, treatment and repair of connective tissues in humans and animals comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothionine, one or more avocado/soybean unsaponifiables, and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.

Abstract: Disclosed is a chewing gum composition capable of eliminating nicotine component from the body of a person chewing the chewing gum. Such a chewing gum composition functions to convert the nicotine produced in a human body after smoking to cotinine and to discharge the cotinine into urine. Accordingly, by chewing the chewing gum of the present invention, not only nicotine can be eliminated from the body, but also the incidence of cancer due to nicotine can be largely reduced.

Abstract: The present invention relates to the use of DHEA and/or of at least one precursor or derivative thereof in or for the manufacture of a composition for topical application to the skin, as an agent for preventing or reducing the weathered appearance of the skin.

Abstract: An ulcerative colitis treating therapeutic agent which is very effective in repairing damaged tissues of ulcerative colitis and yet has no need of fear of side effects as those of steroids is provided. It is an therapeutic agent for treating ulcerative colitis which has peony root, especially, dry powders of peony root, or a Chinese medicine formulation containing peony root as an active ingredient. It is also an therapeutic agent for treating ulcerative colitis which has, as an active ingredient, an infused dry extract of peony root, an infused dry extract of a Chinese medicine formulation containing peony root, or especially an infused dry extract of Jia-Wei-Xiao-Yao-San, Dang-Gui-Shao-Yao-San, Shao-Yao-Gan-Cao-Tang, or Gui-Zhi-Fu-Ling-Wan.

Abstract: An herbal composition is disclosed and claimed. One of the compositions disclosed includes the combination of sage leaf, red raspberry leaf, bayberry bark, capsicum pepper, damiana leaf, ginger root, licorice root, vaierian root, black cohosh root, red clover extract and kudzu root. Other compositions of the herbs are disclosed and claimed. The composition is bound in tablet form and administered orally. Alternatively, the composition is applied to the skin of the user as a cream, a patch or spray.

Abstract: A composition comprising Denhichi, Tochu and Osei, wherein the Denhichi is Panax pseudo-ginseng, the Tochu is Eucommiae ulmoides and the Osei is selected from the group consisting of Polygonati Rhizoma, Polygonatum falcatum, other plants belonging to the genus Polygonatum, and Siberian Solomonseal Rhizome.

Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a soy molasses material. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.

Abstract: Disclosed is a “Pet Food Formulation System” (PFFS) that is a “treatment system” that results in loss of weight by pets consuming ad libitum, or in controlled rations, a reduced calorie pet food. The PFFS will comprise the use of jojoba meal (JM) in the form of whole fat jojoba seed flour (WFJSF), expeller pressed jojoba seed meal, and/or solvent extracted jojoba seed meal, in combination with simmondsin concentrate (SC) and jojoba oil (JO), such combinations designed to both reduce the quantity of pet food consumed by the pet and at the same time reduce the level of calories contributed by the pet food that is consumed. Simmondsin concentrate and the natural simmondsin content of jojoba meal contained in a pet food for consumption by either dogs or cats serves to reduce pet appetite and therefore the amount of food that the pet is inclined to consume.

Abstract: The present invention provides compositions, therapeutic combinations and methods including: (a) at least one hormone replacement therapy composition; and (b) at least one sterol absorption inhibitor which can be useful for treating vascular conditions in post-menopausal women and lowering plasma levels of sterols or 5&agr;-stanols.

Abstract: A therapeutic composition for treating diabetes includes mixing of the following ingredients:

Abstract: The invention concerns a method for selectively extracting furan lipids and polyhydroxylated fatty alcohols of avocado, characterised in that it comprises steps which consist in: preparing an unsaponifiable matter of avocado; then in subjecting the unsaponifiable matter of avocado to a step of molecular distillation using adjusted temperature and pressure means to obtain either a distillate comprising mainly furan lipids and polyhydroxylated fatty alcohols of avocado. Said method enables in particular to extract selectively furan lipids of avocado having a furan lipid content of more than 80 wt. %, even close to 98%.

Abstract: A therapeutic oil composition is provided that is useful for topical application to painful areas of the human body. The therapeutic oil composition is created by mixing essentials oils of Eugenia caryophyllata, Myroxylon balsamum var. pereirae, Eucalyptus globulus var. globulus, Lavandula augustifolia, Mentha piperita, and Mentha spicata. The volume of each constituent added can be modified according to the desired treatment. The mixture is then aged by storing it in the dark at a temperature of between 50° F. to 60° F. for at least thirty-six hours. The composition may be applied topically in 100% strength, or mixed with an oil-based carrier, and allowed to enter through the skin and into the tissue to relieve complaints of physical pain, including muscular aches and pains, arthritis and respiratory distress.